Life Sciences Central to Telangana’s $3-Trillion Vision: Minister Sridhar Babu
Hyderabad, Feb 18: The Telangana government has set an ambitious goal of building a $3-trillion economy by 2047, with the life sciences sector identified as a key growth engine, IT and Industries Minister D. Sridhar Babu said on Wednesday.
Addressing the valedictory session of BioAsia 2026 at HITEX, the Minister stated that the State’s long-term development blueprint, “Telangana Rising 2047,” was formulated through extensive consultations with citizens, industry leaders, and domain experts. The initiative aims to significantly expand Telangana’s economic footprint and raise its contribution to the national GDP to 10 percent over the coming decades.
Earlier, during a fireside chat titled “Telangana Rising 2047: Building a World-Class Life Sciences Ecosystem,” Mr. Sridhar Babu outlined a comprehensive roadmap to position Telangana as a global hub for life sciences. He emphasized that the sector would play a pivotal role in achieving the State’s long-term economic targets. Since December 2023, Telangana has attracted ₹73,360 crore in life sciences investments, creating nearly one lakh employment opportunities, he noted.
Detailing the government’s strategy to strengthen the ecosystem, the Minister highlighted several flagship initiatives, including the Telangana Next-Gen Life Sciences Policy (2026–2030), the proposed Telangana Life Sciences School, and the OneBio Incubator. He also pointed to the ongoing expansion of Genome Valley, development of dedicated Pharma Villages, and the creation of world-class infrastructure supported by global partnerships and a highly skilled talent pool.
Underscoring the State’s strong industrial foundation, Mr. Sridhar Babu said Telangana is home to over 2,000 life sciences companies. The State contributes nearly one-third of India’s pharmaceutical production and accounts for about one-fifth of the country’s pharma exports, reinforcing its position as one of India’s leading pharmaceutical and biotechnology hubs.
He revealed that several global companies—including Sanofi, Opella, Vaxxinova Animal Health, Tredence, and Rx Propellant—expressed interest in investing in Telangana during the summit, reflecting growing international confidence in the State’s innovation ecosystem.
The event also featured special roundtable meetings with experts from the United Kingdom, New Zealand, South Korea, Australia, and Japan, focusing on emerging challenges, technology trends, and collaboration opportunities in life sciences. Discussions were also held with representatives of the World Economic Forum on strategies to position India as the world’s third-largest bioeconomy, with Telangana expected to play a significant role. A detailed roadmap is currently under preparation.
BioAsia 2026 witnessed participation from 4,394 delegates from India and abroad, including representatives of Fortune 500 companies. The summit hosted more than 4,000 high-level business-to-business meetings, aimed at fostering investments, technology transfers, and global partnerships.
Concluding his address, the Minister stressed that the government views life sciences not merely as a commercial sector but as a field with profound social impact, particularly in healthcare, biotechnology innovation, and sustainable development. He invited global industry leaders to collaborate with Telangana in driving innovation-led growth and shaping the future of life sciences.
